Reminder – Melanoma Consumer Breakfast this Saturday 6th October 2108

Sat 6th October 2018, 8:00-9:30am All members of the melanoma community are invited to attend a Melanoma Consumer Breakfast. The Breakfast is part of the Australasian Melanoma Conference – which also has great consumer forums. The program is on the website. All bookings can be made via the conference website

Melanoma survivors march to honour lost friends and raise awareness

Melanoma has a reputation for being one of the most curable types of cancers, but that does not mean much to survivors such as Jay Allen and Aaron Kelly.

Free skin checks for South West community

The Bunbury Skin Cancer Clinic is partnering with melanomaWA to provide the community with free skin checks on February 24.

Townsville’s First Ever Twilight Melanoma March

She will next month join Townsville’s first ever twilight Melanoma March in honour of her mother, Gina Sellen, who lost her battle against the deadly cancer in 2016.

Cancer in the News

Feature Articles

Clinicopathological factors associated with death from thin (? 1·00 mm) melanoma

Researchers conducted a large, nested case–case study including data from the population-based Queensland Cancer Registry, Australia in order to recognize the clinicopathological factors associated with fatal thin melanomas.


Posted in Melanoma News, Health Professionals, Of Interest

Spartalizumab Plus Dabrafenib/Trametinib Impresses in BRAF+ Melanoma With Poor Prognosis

A triplet combining the PD-1 inhibitor spartalizumab with dabrafenib (Tafinlar) and trametinib (Mekinist) led to a 12-month overall survival (OS) rate of 86.1% for patients with previously untreated advanced BRAF V600–mutant melanoma, according to pooled findings from the phase III COMBI-i trial presented during the 16th International Congress of the Society for Melanoma Research.1


Posted in Melanoma News, Health Professionals, Of Interest

First-in-Human Trial for Tebentafusp In Advanced Melanoma Shows Promising Safety Profile

Findings from the first-in-human trial evaluating tebentafusp (IMCgp100), a TCR–CD3 bispecific, in patients with advanced melanoma show tebentafusp not only working but showing a favorable safety profile, according to Alexander N. Shoushtari, MD.


Posted in Melanoma News, Health Professionals, Video Reports

Forgot to apply sunscreen? There’s a vending machine for that

In a city with a rate of melanoma higher than the national average, a new sun smart tactic is being trialled which will see machines that dispense sunscreen installed at local beaches and parks.


Posted in Melanoma News, Patients, Latest News

2019 Events

Calculate your risk of getting melanoma Sunscreen calculator
Map of body for recording areas of skin causing you concern on your body Target Therapy Finder